Exchange: NASDAQ·Updated 07:36 PM EDT
QDEL logo

QDELQuidelortho Corp

$18.25
$0.07
(0.39%)
Today
Closed $18.25
$0.23
(1.26%)
After Hours
EarningsJul 29
Mkt Cap$1.24B
Vol1.22M
News
all
press releases
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?
QuidelOrtho (QDEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
News Placeholder
More News
News Placeholder
QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally
QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times reported over the weekend.
Stocktwits
News Placeholder
QuidelOrtho Names Micah Young CFO As Joseph Busky Sets To Retire
(RTTNews) - QuidelOrtho Corporation (QDEL), a provider of diagnostic solutions, Tuesday announced that it has appointed Micah Young as Chief Financial Officer, effective July 6...
Nasdaq News: Markets
News Placeholder
QuidelOrtho Appoints Micah Young as Chief Financial Officer
QuidelOrtho Appoints Micah Young as Chief Financial Officer QuidelOrtho Appoints Micah Young as Chief Financial Officer PR Newswire SAN DIEGO, June 23, 2026 Seasoned medical technology finance executive brings more than two decades of leadership at global public companiesSAN DIEGO, June 23, 2026...
PR Newswire
News Placeholder
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock?
AtriCure (ATRC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
News Placeholder
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.
Zacks
News Placeholder
Is the Options Market Predicting a Spike in QuidelOrtho Stock?
Investors need to pay close attention to QDEL stock based on the movements in the options market lately.
Zacks
News Placeholder
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.
Zacks
<
1
2
...
>

Advertisement|Remove ads.